Kinnari Patel - President, Head of R&D and Chief Operating Officer at Rocket Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President, Head of R&D and Chief Operating Officer
Stock Symbol
RCKT, RCKTW on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Kinnari Patel - trading volume in the past year for Rocket Pharmaceuticals, Inc.

Holdings reported by Kinnari Patel for Rocket Pharmaceuticals, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 400,972 $9.36 M $23.35 May 16, 2024 Direct
Common Stock 104,927 $2.45 M $23.35 May 14, 2024 By Adaptive Technology LLC
Stock Option (Right to Buy) 98,183 $1.37 M $13.93 Feb 16, 2024 Direct Common Stock
Restricted Stock Units 44,268 $1.2 M $27.20 Feb 14, 2024 Direct Common Stock
Common Stock 5,675 $133 K $23.35 May 14, 2024 By Spouse

Transactions reported by Kinnari Patel for Rocket Pharmaceuticals, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership